Sakaguchi M - Search Results

1

Effects of a new 12-lipoxygenase inhibitor, daphnodorin A, on angiotensin II-induced vascular contraction in hamster.

Takai S, Jin D, Sakaguchi M, Kirimura K, Ikeda J, Baba K, Fujita T, Miyazaki M. Takai S, et al. Among authors: sakaguchi m. Prostaglandins Leukot Essent Fatty Acids. 1999 Feb;60(2):135-8. doi: 10.1054/plef.1998.0020. Prostaglandins Leukot Essent Fatty Acids. 1999. PMID: 10328335

2

Effects of daphnodorin A, daphnodorin B and daphnodorin C on human chymase-dependent angiotensin II formation.

Takai S, Sakaguchi M, Jin D, Baba K, Miyazaki M. Takai S, et al. Among authors: sakaguchi m. Life Sci. 1999;64(21):1889-96. doi: 10.1016/s0024-3205(99)00135-6. Life Sci. 1999. PMID: 10353587

3

Effects of a lipoxygenase inhibitor, panaxynol, on vascular contraction induced by angiotensin II.

Takai S, Jin D, Kirimura K, Ikeda J, Sakaguchi M, Baba K, Fujita T, Miyazaki M. Takai S, et al. Among authors: sakaguchi m. Jpn J Pharmacol. 1999 May;80(1):89-92. doi: 10.1254/jjp.80.89. Jpn J Pharmacol. 1999. PMID: 10446762 Free article.

4

The functional ratio of chymase and angiotensin converting enzyme in angiotensin I-induced vascular contraction in monkeys, dogs and rats.

Jin D, Takai S, Yamada M, Sakaguchi M, Miyazaki M. Jin D, et al. Among authors: sakaguchi m. Jpn J Pharmacol. 2000 Dec;84(4):449-54. doi: 10.1254/jjp.84.449. Jpn J Pharmacol. 2000. PMID: 11202618 Free article.

5

Different angiotensin II-forming pathways in human and rat vascular tissues.

Takai S, Sakaguchi M, Jin D, Yamada M, Kirimura K, Miyazaki M. Takai S, et al. Among authors: sakaguchi m. Clin Chim Acta. 2001 Mar;305(1-2):191-5. doi: 10.1016/s0009-8981(01)00379-5. Clin Chim Acta. 2001. PMID: 11249939

6

An orally active chymase inhibitor, BCEAB, suppresses heart chymase activity in the hamster.

Takai S, Jin D, Sakaguchi M, Kirimura K, Miyazaki M. Takai S, et al. Among authors: sakaguchi m. Jpn J Pharmacol. 2001 May;86(1):124-6. doi: 10.1254/jjp.86.124. Jpn J Pharmacol. 2001. PMID: 11430464 Free article.

7

Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein.

Takai S, Jin D, Nishimoto M, Yuda A, Sakaguchi M, Kamoshita K, Ishida K, Sukenaga Y, Sasaki S, Miyazaki M. Takai S, et al. Among authors: sakaguchi m. Life Sci. 2001 Aug 31;69(15):1725-32. doi: 10.1016/s0024-3205(01)01255-3. Life Sci. 2001. PMID: 11665834

8

Chymase-dependent angiotensin II formation in human vascular tissue.

Takai S, Jin D, Sakaguchi M, Miyazaki M. Takai S, et al. Among authors: sakaguchi m. Circulation. 1999 Aug 10;100(6):654-8. doi: 10.1161/01.cir.100.6.654. Circulation. 1999. PMID: 10441104

9

Characterization of recombinant human chymase expressed in Escherichia coli.

Takai S, Sumi S, Aoike M, Sakaguchi M, Itoh Y, Jin D, Matsumura E, Miyazaki M. Takai S, et al. Among authors: sakaguchi m. Jpn J Pharmacol. 2000 Feb;82(2):144-9. doi: 10.1254/jjp.82.144. Jpn J Pharmacol. 2000. PMID: 10877533 Free article.

10

A new method for simultaneous measurements of mast cell proteases in human vascular tissue.

Takai S, Sakaguchi M, Jin D, Miyazaki M. Takai S, et al. Among authors: sakaguchi m. Clin Exp Pharmacol Physiol. 2000 Sep;27(9):700-4. doi: 10.1046/j.1440-1681.2000.03323.x. Clin Exp Pharmacol Physiol. 2000. PMID: 10972536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,714 results

Search Page

Filters